Bavarian Nordic A/S (CPH:BAVA)
Denmark · Delayed Price · Currency is DKK 180.60
-2.40 (-1.31%)
Jul 21, 2026, 11:10 AM CET
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of 13.97 billion as of July 20, 2026. Its market cap has decreased by -2.76% in one year.
Market Cap
13.97B
Enterprise Value
11.82B
Revenue
5.96B
Ranking
n/a
PE Ratio
12.34
Stock Price
180.60
ChartMarket Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 42.71M to 13.97B, an increase of 32,612.78%. That is a compound annual growth rate of 23.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 13.97B | -6.46% |
| Dec 30, 2025 | 14.94B | 0.41% |
| Dec 30, 2024 | 14.88B | 7.57% |
| Dec 29, 2023 | 13.83B | -8.19% |
| Dec 30, 2022 | 15.06B | -20.32% |
| Dec 30, 2021 | 18.90B | 73.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.46T |
| Genmab | 114.74B |
| Coloplast | 95.20B |
| Demant | 58.59B |
| H. Lundbeck | 41.26B |
| Zealand Pharma | 20.75B |
| Ambu A/S | 18.23B |
| GN Store Nord | 13.27B |